on October 16, 2006
Published online before print October 16, 2006, doi: 10.1161/CIRCULATIONAHA.106.628396
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on March 20, 2006
From the Angiogenesis Research Center (T.W.C., J.A.S., A.E.H., A.L., J.P., M.S.), Section of Cardiology, Departments of Medicine (T.W.C., J.A.S., A.E.H., A.A.L., J.D.P., M.S.), Pharmacology and Toxicology (M.S.), and Radiology (J.D.P.), and Norris Cotton Cancer Center, Department of Genetics (J.H.M.), Dartmouth Medical School, Hanover, NH; Bioinformatics Programme, Department of Statistics (T.W.C., J.A.S.), and Wellcome Trust Centre for Human Genetics (J.M.T.), University of Oxford, Oxford, UK; Department of Computer Science (F.X., J.D.P.), Dartmouth College, Hanover, NH; and Department of Pathology (H.D., S.M.S.), University of Washington, Seattle. * To whom correspondence should be addressed. E-mail: michael.simons{at}dartmouth.edu.
Background--The development of collateral circulation plays an important role in protecting tissues from ischemic damage, and its stimulation has emerged as one of principal approaches to therapeutic angiogenesis. Clinical observations have documented substantial differences in the extent of collateralization among patients with coronary artery disease (CAD), with some individuals demonstrating marked abundance and others showing nearly complete absence of these vessels. Recent studies have suggested that circulating monocytes play a major role in collateral growth. The present study was undertaken to determine transcriptional profiles of circulating monocytes in CAD patients with different extents of collateral growth. Methods and Results--Monocyte transcriptomes from CAD patients with and without collateral vessels were obtained by use of high-throughput expression profiling. Using a newly developed redundancy-based data mining method, we have identified a set of molecular markers characteristic of a "noncollateralgenic" phenotype. Moreover, we show that these transcriptional abnormalities are independent of the severity of CAD or any other known clinical parameter thought to affect collateral development and correlated with protein expression levels in monocytes and plasma. Conclusions--Monocyte transcription profiling identifies sets of patients with extensive versus poorly developed collateral circulation. Thus, genetic factors may heavily influence coronary collateral vessel growth in CAD and affect prognosis and response to therapeutic interventions.
Revised on August 1, 2006
Accepted on August 11, 2006
Transcriptional Profiling in Coronary Artery Disease. Indications for Novel Markers of Coronary Collateralization
Thomas W. Chittenden PhD,
Key words: angiogenesis • collateral circulation • coronary disease • genes • arteriogenesis
Related Article:
Circulation 2006 114: 1793.
This article has been cited by other articles:
 |
|
 |
|
  D. Chalothorn, H. Zhang, J. E. Smith, J. C. Edwards, and J. E. Faber Chloride Intracellular Channel-4 Is a Determinant of Native Collateral Formation in Skeletal Muscle and Brain Circ. Res., July 2, 2009; 105(1): 89 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Azuaje, Y. Devaux, and D. Wagner Computational biology for cardiovascular biomarker discovery Brief Bioinform, July 1, 2009; 10(4): 367 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P Meier, J Antonov, R Zbinden, A Kuhn, S Zbinden, S Gloekler, M Delorenzi, R Jaggi, and C Seiler Non-invasive gene-expression-based detection of well-developed collateral function in individuals with and without coronary artery disease Heart, June 1, 2009; 95(11): 900 - 908. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Plump and P. Y. Lum Genomics and cardiovascular drug development. J. Am. Coll. Cardiol., March 31, 2009; 53(13): 1089 - 1100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S H Schirmer, F C van Nooijen, J J Piek, and N van Royen Stimulation of collateral artery growth: travelling further down the road to clinical application Heart, February 1, 2009; 95(3): 191 - 197. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Taylor, H. T. Yang, M. H. Laughlin, and R. L. Terjung {alpha}-Adrenergic and neuropeptide Y Y1 receptor control of collateral circuit conductance: influence of exercise training J. Physiol., December 15, 2008; 586(24): 5983 - 5998. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. van Oostrom, O. van Oostrom, P. H. A. Quax, M. C. Verhaar, and I. E. Hoefer Insights into mechanisms behind arteriogenesis: what does the future hold? J. Leukoc. Biol., December 1, 2008; 84(6): 1379 - 1391. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Schirmer, J. O. Fledderus, P. T.G. Bot, P. D. Moerland, I. E. Hoefer, J. Baan Jr, J. P.S. Henriques, R. J. van der Schaaf, M. M. Vis, A. J.G. Horrevoets, et al. Interferon-{beta} Signaling Is Enhanced in Patients With Insufficient Coronary Collateral Artery Development and Inhibits Arteriogenesis in Mice Circ. Res., May 23, 2008; 102(10): 1286 - 1294. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Boodhwani Invited commentary Ann. Thorac. Surg., January 1, 2008; 85(1): 79 - 79. [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Sheridan, M. J. Ferguson, M. R. Distasi, F. A. Witzmann, M. C. Dalsing, S. J. Miller, and J. L. Unthank Impact of genetic background and aging on mesenteric collateral growth capacity in Fischer 344, Brown Norway, and Fischer 344 x Brown Norway hybrid rats Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3498 - H3505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Ashley, J. M. Spin, R. Tabibiazar, and T. Quertermous Frontiers in Nephrology: Genomic Approaches to Understanding the Molecular Basis of Atherosclerosis J. Am. Soc. Nephrol., November 1, 2007; 18(11): 2853 - 2862. [Abstract] [Full Text] [PDF]
|
|